planted. In summary, of the 240 patients for whom the Europdonor office searched for a donor, about onethird were transplanted, one-third had a potential To evaluate the efficiency of our protocol for finding an HLA matched unrelated bone marrow donor, search donor but did not reach transplantation, while for the remaining one 
donors in Europe, Israel, South Africa, North America, Over half of potential donors are coordinated by the Canada, India, Australia and New Zealand has been National Marrow Donor Program (NMDP) and approxiessential in this context. While searching for a suitable mately 40% are included in the European Donor Secretariat donor several problems were encountered such as (EDS) or European Marrow Donor Information System unavailability of donors (12%) and discordant typing (EMDIS) . According to the IMUST study 8 a suitable donor results (8%; range Ͻ1% to Ͼ25%). Thus it is advisable can be found for 10% of patients only, if the search is to select several donors for a patient. For 86% of restricted to a large registry such as the British Bone Marpatients with at least one HLA identical donor on the row and Platelet Donor Panel (BBMPDP) with 40 000 serological level for HLA-A,-B,-DR,-DQ, an HLAdonors at the time of analysis. This figure is much higher DRB1/3/4/5, and -DQB1 identical donor could be identif other registries are contacted as well. [9] [10] [11] [12] ified. As expected, patients with two frequent haplotypes Selection criteria by which a suitable donor is identified, in strong linkage disequilibrium had the best chance of are still in a state of flux as a result of the introduction of obtaining an HLA matched donor. Unexpectedly, new HLA typing technologies, extension of the registries patients with only one such haplotype had an almost and the introduction of new bone marrow transplant similar chance. It could be calculated that HLA-DR protocols.
typing of HLA-A,-B identical donors was rarely cost-
In this report we describe the results of search requests effective after 1992. Only 12 of the 75 transplanted for 240 Dutch patients reported to Europdonor in an attempt patients (16%) typeable at DNA level for class II, turned to document successes and failures of the search process, out to be completely matched for HLA-A,-B,-C,-and if possible their causes. DRB1/3/4/5,-DQB1,-DPB1 and had a negative MLC test. In the group of patients transplanted with a fully matched donor and for whom a CTLp test was perforPatients and methods med, only 7% (4/54) of the tests were negative. Search results for patients of non-European origin were dismal, with only four of 26 patients referred being trans-
The analysis concerned the donor searches for 240 consecutive Dutch patients registered by the Europdonor Foundation from 1990 till 1995. Patients originated from the 15 If the chance is higher The outline of the process for selecting a bone marrow than 1%, which implies that if 10 donors are HLA-DR donor for patients in need of an allogeneic bone marrow typed there is a chance of almost 10% that one donor is donor but lacking an HLA (genotypically) identical sibling donor is given in Figure 1 .
HLA-A,-B and -DR identical, HLA-DR typing is initiated. (Table 3) . Following retyping, discordant results of 8% were mismatch (eg HLA-A24 instead of -A23, HLA-A2 instead of -A28, respectively). At the same time, the chance of observed (Table 3 ). This number did not change during the period studied. It did, however, vary between the registries finding a one locus antigen mismatched family donor is calculated. 13 All donors requested for a patient are retyped from less than 1% to over 25% (mean = 8%; median = 11%). Donors from registries with more than 50 000 donors using serological methods. From 1992 onwards, patient and donors have also been subtyped at DNA level for HLAhad on average more discordant results (mean = 10%; median = 12%) than registries with less than 50 000 donors DRB1/3/4/5 and increasingly for HLA-DQB1, -DPB1, -A2 and -C. The mixed lymphocyte culture test is performed (mean = 3%; median 8%). In 37 out of 73 (51%), the discordant results involved homozygosity, ie donor centre routinely and the cytotoxic T lymphocyte precursor (CTLp) test performed if possible.
typed the donor as homozygous while the donor was heterozygous and visa versa, ie the donor was typed as heterozygous but was in fact homozygous for that locus. For 8% HLA serology of patients the only donor thought to be present, turned out to be either not available (4%) or mistyped (4%). All HLA-A,-B and -C typings of patients and retypings of donors were done using the standard NIH lymphocytotoxicity assay and the HLA-DR and -DQ was performed with the two colour fluorescence assay 16 using allo-antisera.
Percentage of patients for whom an HLA-A,-B, -DRB1/3/4/5,-DQB1 identical donor could be found DNA typing
Analysis is restricted to the years 1992-1995, because DNA HLA-DRB1 typing was performed using biotinylated typing was introduced as a routine technique in the middle sequence-specific oligonucleotides from 1992 to 1993 17 and of 1992. The data analysed consisted of 441 HLA-A,-B, from 1994 to 1995 using the PCR-SSP technique. 18 The -DR,-DQ serologically split matched donors tested for 97 HLA-DPB1 typing was done with similar methods using patients. The mean number of donors tested per patient was three primer sets, one generic set and the other two separat-4.5; the median 5.0 and the range 1-17 donors. Seventying the DPB1 specificities into two groups. Twenty-one five percent of all HLA-A,-B,-DR,-DQ split identical DPB1 sequence-specific oligonucleotides were used to donors based on serology were also identical to the patient detect 36 different DPB1 specificities. HLA-C typing was for HLA-DRB1/3/4/5 and 13% for HLA-DRB1/3/4/5, performed according to the method of Bunce et al. 19 When--DQB1 and -DPB1. For 86 of the 97 patients (89%) one (or ever possible, patient/donor pairs not yet typed at the DNA more) HLA-,A,-B,-DRB1,-DQB1 identical donor(s) were level, were typed retrospectively.
identified. This figure was only reduced by 3% to 86% when identity for DRB3/4/5 was also included in the analysis. Of these, only 28% were also HLA-DPB1 identical.
Mixed lymphocyte culture (MLC) test
The mixed lymphocyte cultures were performed according to Keuning et al. 20 Tests were defined as negative when Impact of linkage disequilibrium on the outcome of the the relative response value was equal to or less than 10%.
search process
Cytotoxic T lymphocyte precursor (CTLp) test
To establish whether the linkage disequilibrium of the patients' haplotypes would be helpful in predicting whether The CTLp test was performed as described by Zhang et an HLA-A,-B,-DRB1/3/4/5,-DQB1 identical donor could al 21 with minor modifications. In each test, donor cells were be identified, the 97 patients described above were subdivused as responder cells and patient cells as stimulator and ided into those with two (FF), one (FN) or no haplotypes target cells. A negative CTLp test was defined as less than (NN) in strong linkage disequilibrium. A frequent haplo-2 CTLps per 10 6 peripheral blood lymphocytes, a doubtful type in this analysis was defined as a haplotype belonging positive result was defined as у2 and Ͻ8 and a positive to the 10 haplotypes with strongest linkage disequilibrium result as у8 CTLps per 10 6 peripheral blood lymphocytes. in the Dutch population. 22 The 11 patients with two haplotypes in strong linkage disequilibrium had, as expected, a very high success rate (100%) in locating an HLA-A,-B, Results -DRB1/3/4/5,-DQB1 identical donor, but also those patients (n = 45) who had only one such haplotype had a high sucNumber of potentially available donors cess rate (91%). The chance of finding such a donor for patients (n = 41) with no haplotype in strong linkage dis- Table 2 illustrates the rise of potentially HLA-A,-B,-DR identical donors (at the split level) available for patients in equilibrium was 78% (P = NS). The chance of finding an HLA-DPB1 identical donor was significantly increased in the years 1990-1995 in either the Dutch Europdonor registry or in BMDW. From these potentially acceptable donors the FF group (63%; P = 0.04) compared to the combined FR and RR group (23%). a mean number of 6.7 donor blood samples per patient were Table 3 The number of HLA-A,-B,-DR typed donors requested, their availability and discordant HLA typing of the donors requested 
HLA-DR typing of HLA-A,-B identical donors
received an HLA mismatched graft. HLA typing at the DNA level was performed for some of the patient/donor HLA-DR typing was effective in the years 1990-1992 combinations retrospectively. Most patient/donor pairs when 12 donors were identified for eight out of 30 patients were found to be either mismatched for class I (A,B or C) after 215 HLA-DR typing procedures. In contrast, in the and/or class II (DRB1/3/4/5,DQB1 or DPB1) or had a posiyears 1993-1995, HLA-DR typing was requested sporaditive MLC or CTLp test. In the majority of the cases studied, cally and was always unsuccessful in identifying an HLAthe class I mismatches could be shown to be due to mis-A,-B,-DR identical donor. matches at the HLA-C locus (18/24). Twelve patients (16%) appeared to be transplanted with a well matched donor, ie identical for HLA-A,-B,-C,-DRB1/3/4/5,-DQB1,
Percentage of patients who did not reach transplantation and the reasons why
-DPB1, MLC negative (Table 4 ). Ten out of these 12 patients survived and are remarkably well (manuscript in Eighty-six (36%) out of the 240 patients were transplanted. preparation). Thirty-one patients (13%) were actively withdrawn from the search process, generally because of a reassessment of the indication for transplantation. Seventeen percent of Length of time between search request and patients died or were not transplantable due to advanced transplantation disease status. The percentage of patients who could not be transplanted because a donor was not found dropped from Less than 1 day was needed to identify a potential donor in Europdonor due to the computer register being on site. 50% in 1990-1991 to 21% in 1994-1995. The percentage of patients who could be transplanted rose from an average For the other registries, where transmission of requests and results was necessary, this interval decreased between 1990 of 24% in 1990-1991 to 44% in 1994-1995. and 1995 from a median of 11 days to 4 days. The time needed to obtain a blood sample from a potential donor Donor-recipient disparities for HLA differed substantially between registries but was a median of 9 days (range 1-38) for donors from the Europdonor file Although the a priori aim of the search was to find HLA split identical donors, a large percentage of patients actually and 19 days (range 3-149) from elsewhere. It should be patients transplanted is higher than reported elsewhere. fusion donors and apheresis donors have a lower unavailability rate (16.7%) than donors recruited by community drives (26.4%). In Europdonor, where mostly blood transnoted that samples from other registries were obtained fusion donors who have donated at least twice are recruited much faster in 1993-1995 than before 1993. The time as bone marrow donors, no increase in donor withdrawal needed for donor identification and the time to transplanrate is seen over the years (9% in 1990 and 10% in 1995). tation was substantially shorter for donors residing in The
The overall percentage of donors with HLA typing errors Netherlands compared to international donors; 3.0 vs 5.1 is 8% but varies between the different registries from less months for donor choice and 5.1 vs 7.0 months for time to than 1% to over 25%. Homozygosity either missed or incortransplantation. It is unclear to what extent this difference rectly assumed to be present, was the cause of almost half in time interval is caused by the fact that for patients with of the mistypings. It is thus advisable to request a higher a common phenotype there will be several potential donors number of donors for testing when the patient is homoin the national file.
zygous for one or more loci. The inclusion of the MLC and CTLp test in our protocol deserves a comment. Several publications stress that an
Search outcome for patients from non-European origin
MLC test is often uninterpretable and taken alone is not a The percentage of patients of non-European origin rose predictor of a better transplant prognosis. [25] [26] [27] We agree that from 5% in 1990 to 16% in 1995. In total, 26 of the 240 the outcome of the MLC test alone is not a useful criterion patients were of non-European origin. For seven patients for donor selection. We still perform the MLC test as a (27%) an HLA-A,-B,-DR split identical donor could be control for HLA-DRB1 typing as new alleles may not be identified in BMDW. Only four out of the 26 patients, of detected by the PCR-based typing technique used, and to whom two were an identical twin, were transplanted. For answer the question whether it is a predictor of GVHD or the remaining three patients with a potential donor, the relapse in combination with HLA-DPB1. search was stopped; one patient for personal reasons, for
The outcome of the CTLp test is useful for selecting the one patient HLA subtyping of the donor revealed too many best donor as has been documented by others. [28] [29] [30] It recogmismatches and for one patient due to advanced disease nizes mismatches for class I, including HLA-C alleles, and status.
serves as a check for the correctness of HLA class I typing. Theoretically, it could recognize minor histocompatibility mismatches but we have not encountered that.
31

Discussion
Thirteen percent of patients (n = 31) were withdrawn during the search process for reasons other than the unavailThis study has been useful in pinpointing some of the ability of an unrelated donor. The reasons (n = 20) were obstacles encountered when searching for an HLA matched therapy-resistant leukaemia, unwillingness of the patient to unrelated donor.
be transplanted (n = 6), or the identification of a suitable The analysis of the 240 searches showed that in 1995 related donor after an extended family search (n = 5). For for over 70% of the patients an HLA-A,-B,-DR split ident-17% of patients for whom an unrelated donor was available ical donor was available among the more than 500 000 split the patient may have been referred to the transplant centre typed donors reported in BMDW. This is approximately too late or the search process took too long. They were 10% higher than predicted by Beatty et al 23 plicated process of finding and selecting an unrelated donor and obtaining, transporting and transplanting the bone marThis figure is much higher than is reported in the literature.
11 One reason may be that we, whenever possible, selrow, intensive interaction between the registry staff, the immunogeneticist, immunologist and clinician is essenect donors beforehand who are also identical for HLA-C and -DQ. Testing for DRB3,4 or 5 did not change the numtial. 32 It is only in this way that the patient can be optimally helped and that opportunities such as finding a suitable bers while DPB1 was only matched in 28% of the patients who were HLA-A,-B,-DRB1/3/4/5,-DQB1 identical. This family donor outside the core family through an extended family search are not missed. figure is higher than reported elsewhere, 9,12,33 possibly because of a larger number of donors tested per patient by us (mean 6.7). These figures were reduced markedly for donors with either an HLA-A or -B locus mismatch. In this Acknowledgements situation only 50% of patients had at least one HLA-A or frequencies of the two most common haplotypes out of the six possible. If one haplotype is very frequent and the number of donors is large, we can equal the chance to one.
References In other words, finding a donor with that haplotype is not restricted. As a result, the frequency of the less frequent
